Biocon

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn

September 17, 2021

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn

As part of the deal, Biocon Biologics and Serum Institute Life Sciences will make and distribute vaccines and antibodies.

August 18, 2020
Biocon executive chairperson Kiran Mazumdar-Shaw tests positive for COVID-19

Replying to her tweet, Congress MP Shashi Tharoor said, 'So sorry to hear this, @KiranShaw. We need you hale & hearty soon! Be well my friend.'